AlphaFold predicted structure
CSGALNACT1 · Q8TDX6

Mean pLDDT
87.3/ 100
Confident
532 residues
Confidence breakdown
- Very high(≥ 90)64%
- Confident(70–90)25%
- Low(50–70)6%
- Very low(< 50)5%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
chondroitin sulfate N-acetylgalactosaminyltransferase 1
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Congenital disorders of glycosylation
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalSkeletal dysplasia
BIALLELIC, autosomal or pseudoautosomalskeletal dysplasia, mild, with joint laxity and advanced bone age
congenital disorder of glycosylation
Abnormality of the skeletal system
Desbuquois syndrome
alcohol drinking
Vertigo
placenta praevia
metabolic syndrome
venous thromboembolism
hyperlipidemia
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Chondroitin sulfate N-acetylgalactosaminyltransferase 1
Transfers 1,4-N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of glucuronic acid (GlcUA). Required for addition of the first GalNAc to the core tetrasaccharide linker and for elongation of chondroitin chains. Important role in chondroitin chain biosynthesis in cartilage formation and subsequent endochondral ossification (PubMed:11788602, PubMed:12163485, PubMed:12446672, PubMed:17145758, PubMed:31705726). Moreover, is involved in the metabolism of aggrecan (By similarity)
CSGALNACT1 · Q8TDX6

Mean pLDDT
87.3/ 100
Confident
532 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0